Daiwa Securities Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-309
| Closed | -$52K | – | 1296 |
|
|
2025
Q4 | $52K | Buy |
309
+297
| +2,475% | +$48.2K | ﹤0.01% | 1113 |
|
|
2025
Q3 | $2K | Sell |
12
-912
| -99% | -$124K | ﹤0.01% | 1271 |
|
|
2025
Q2 | $117K | Buy |
924
+510
| +123% | +$62.6K | ﹤0.01% | 994 |
|
|
2025
Q1 | $53K | Sell |
414
-627
| -60% | -$85K | ﹤0.01% | 1016 |
|
|
2024
Q4 | $138K | Buy |
1,041
+13
| +1% | +$1.83K | ﹤0.01% | 976 |
|
|
2024
Q3 | $150K | Buy |
1,028
+110
| +12% | +$15.9K | ﹤0.01% | 982 |
|
|
2024
Q2 | $126K | Buy |
918
+59
| +7% | +$7.88K | ﹤0.01% | 1021 |
|
|
2024
Q1 | $118K | Buy |
859
+10
| +1% | +$1.37K | ﹤0.01% | 1038 |
|
|
2023
Q4 | $115K | Sell |
849
-383
| -31% | -$46.7K | ﹤0.01% | 998 |
|
|
2023
Q3 | $151K | Buy |
1,232
+225
| +22% | +$28.6K | ﹤0.01% | 989 |
|
|
2023
Q2 | $128K | Sell |
1,007
-53
| -5% | -$6.88K | ﹤0.01% | 981 |
|
|
2023
Q1 | $137K | Buy |
1,060
+535
| +102% | +$70K | ﹤0.01% | 964 |
|
|
2022
Q4 | $69K | Sell |
525
-1,057
| -67% | -$137K | ﹤0.01% | 1004 |
|
|
2022
Q3 | $185K | Sell |
1,582
-2,328
| -60% | -$289K | ﹤0.01% | 951 |
|
|
2022
Q2 | $460K | Sell |
3,910
-1,169
| -23% | -$139K | ﹤0.01% | 837 |
|
|
2022
Q1 | $662K | Buy |
5,079
+1,136
| +29% | +$148K | ﹤0.01% | 794 |
|
|
2021
Q4 | $602K | Buy |
3,943
+802
| +26% | +$124K | ﹤0.01% | 823 |
|
|
2021
Q3 | $508K | Sell |
3,141
-4,049
| -56% | -$681K | ﹤0.01% | 841 |
|
|
2021
Q2 | $1.18M | Buy |
7,190
+791
| +12% | +$122K | 0.01% | 598 |
|
|
2021
Q1 | $963K | Buy |
6,399
+3,257
| +104% | +$517K | 0.01% | 631 |
|
|
2020
Q4 | $476K | Sell |
3,142
-15,119
| -83% | -$2.16M | ﹤0.01% | 775 |
|
|
2020
Q3 | $2.47M | Buy |
18,261
+7,515
| +70% | +$1.02M | 0.02% | 294 |
|
|
2020
Q2 | $1.16M | Hold |
10,746
| – | – | 0.02% | 324 |
|
|
2020
Q1 | $1.16M | Buy |
10,746
+1,534
| +17% | +$177K | 0.01% | 435 |
|
|
2019
Q4 | $1.11M | Buy |
9,212
+2,547
| +38% | +$284K | 0.01% | 496 |
|
|
2019
Q3 | $663K | Buy |
6,665
+770
| +13% | +$80.6K | 0.01% | 613 |
|
|
2019
Q2 | $643K | Buy |
5,895
+1,820
| +45% | +$194K | 0.01% | 589 |
|
|
2019
Q1 | $456K | Sell |
4,075
-1,814
| -31% | -$199K | ﹤0.01% | 673 |
|
|
2018
Q4 | $568K | Sell |
5,889
-4,480
| -43% | -$476K | 0.01% | 568 |
|
|
2018
Q3 | $1.26M | Buy |
10,369
+6,470
| +166% | +$762K | 0.01% | 459 |
|
|
2018
Q2 | $428K | Buy |
3,899
+1,413
| +57% | +$151K | ﹤0.01% | 684 |
|
|
2018
Q1 | $265K | Buy |
+2,486
| New | +$276K | ﹤0.01% | 784 |
|
Other funds holding IBB
CB
Daiwa Securities Group's IBB Position: Q1 2026 in Review
Daiwa Securities Group sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 309 shares — an estimated $52K sold.
Daiwa Securities Group first reported a position in IBB in Q1 2018 and held it in 32 quarters. The position peaked at $2.47M in Q3 2020. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Daiwa Securities Group reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 309 iShares Biotechnology ETF shares in Q1 2026, an estimated $52K.
- Daiwa Securities Group first reported a position in iShares Biotechnology ETF in Q1 2018 and held it in 32 quarters.
- Daiwa Securities Group's iShares Biotechnology ETF position peaked at $2.47M in Q3 2020.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.